Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · IEX Real-Time Price · USD
0.550
+0.010 (1.89%)
Feb 26, 2024, 1:33 PM EST - Market open

Moleculin Biotech Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Selling, General & Admin
11.548.396.796.315.234.092.380.330.84
Research & Development
18.9714.4212.7611.019.734.551.50.130.8
Other Operating Expenses
0.130.160.20.20.070.020.010.010.01
Operating Expenses
30.6422.9719.7417.5215.038.653.880.471.65
Operating Income
-30.64-22.97-19.74-17.52-15.03-8.65-3.88-0.47-1.65
Interest Expense / Income
0000000.040.450.16
Other Expense / Income
-1.62-7.07-2.39-4.09-3.151.15--0.55-0
Pretax Income
-29.03-15.89-17.36-13.43-11.88-9.81-3.93-0.37-1.81
Income Tax
000-0.2300000
Net Income
-29.03-15.89-17.36-13.21-11.88-9.81-3.93-0.37-1.81
Shares Outstanding (Basic)
29271074321-
Shares Outstanding (Diluted)
2927107432--
Shares Change
6.43%172.97%45.07%57.20%39.50%88.95%48.76%--
EPS (Basic)
-1.01-0.59-1.76-1.95-2.76-3.18-2.40--
EPS (Diluted)
-1.01-0.59-1.76-1.95-2.76-3.18-2.40--
Free Cash Flow
-27.71-18.97-18.15-17.25-12.62-7.35-3.79-0.72-1.35
Free Cash Flow Per Share
-0.97-0.71-1.84-2.54-2.92-2.38-2.31-0.66-
EBITDA
-28.9-15.73-17.16-13.24-11.81-9.79-3.880.1-1.64
Depreciation & Amortization
0.130.160.20.20.070.020.010.010.01
EBIT
-29.03-15.89-17.36-13.43-11.88-9.81-3.880.08-1.65
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).